Palatin Technologies Inc.
-
Ticker
PTN
-
Industry
Diagnostic Substances More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Cranbury, New Jersey
Palatin Technologies, Inc., a biopharmaceutical company, develops peptide, peptide mimetic, and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems in the United States.
REPORT RATINGS
4.8 / 5.0 (144)
Palatin Technologies Inc. reports have an aggregate usefulness score of 4.8 based on 144 reviews.
Palatin Technologies Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports